Yarrow Bioscience (YARW) Shares Outstanding (2016 - 2026)

Yarrow Bioscience (YARW) has 11 years of Shares Outstanding (Entity) data on file, last reported at $855360.0 in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.22% year-over-year to $855360.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $855360.0 (changed 0.22% YoY) and the FY2025 annual result came in at $855360.0, changed 0.42% from the prior year.
• Shares Outstanding (Entity) was little changed at $855360.0 in Q1 2026, from $855360.0 in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $855360.0 in Q4 2025 to a low of $64348.0 in Q1 2022.
• A 5-year average of $467921.2 and a median of $528540.0 in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) jumped 1201.65% — and 2025, when it advanced 0.22%.
• Tracing YARW's Shares Outstanding (Entity) over 5 years: stood at $64594.0 in 2022, then surged by 218.08% to $205460.0 in 2023, then jumped by 314.57% to $851780.0 in 2024, then grew by 0.42% to $855360.0 in 2025, then changed by 0.0% to $855360.0 in 2026.
• The last three Shares Outstanding (Entity) figures came in at $855360.0 (Q1 2026), $855360.0 (Q4 2025), and $855180.0 (Q2 2025), per Business Quant data.